Investors Contact Payment Careers Research Request
Interpace Biosciences®, Inc.
  • Home
  • About
    • Overview
    • Management Team
    • Board of Directors
  • Diagnostics
  • Pharma Solutions
  • Support
  • Labs
  • News & Media
    • Press Releases
    • In The News
    • Presentations
    • Events
  • Investors
  • Contact
  • Payment
  • Careers
  • Research Request

Press Releases

News & Media

News & Media

  • Press Releases
  • In The News
  • Presentations
  • Events

Interpace Diagnostics Announces Receipt of Letter From Nasdaq Confirming Compliance With Minimum Stockholders' Equity Requirement

Apr 13, 2017

Interpace Diagnostics Announces European Patent Approval For Underlying Technology of its ThyraMIR® microRNA Classifier

Apr 3, 2017

Interpace Diagnostics Group Reports Fourth Quarter and Full Year 2016 Financial Results, Business Progress Against Plan and Recent Accomplishments

Mar 29, 2017

Interpace Diagnostics Group Announces Timing of Earnings Release and Investor Conference Call

Mar 28, 2017

Interpace Diagnostics Group Announces Agreements to Successfully Restructure Debt and Terminate Royalty and Milestone Obligations

Mar 23, 2017

Interpace Diagnostics Participates in USA Today Endocrine Health Campaign

Mar 20, 2017

Interpace Diagnostics to Present New Data on Thyroid Product Performance

Feb 27, 2017

Interpace Diagnostics Enters into Collaborative Agreement with Viatar CTC Solutions to Detect and Characterize Early Cancer in Liquid Biopsies

Feb 21, 2017

Interpace Diagnostics to Present at 2017 BIO CEO & Investor Conference

Feb 10, 2017

Interpace Diagnostics Announces Closing of $3.9 Million Public Offering

Feb 8, 2017
    • 1...
    • 13
    • 14
    • 15
    • 16
    • 17
    • 18
    • 19
    • 20
    • 21
    • 22
    © 2023 Interpace Biosciences®, Inc. All Rights Reserved.
    Privacy Policy HIPAA Privacy Disclaimer Sitemap
    We Own Our Future Logo
    • Linkedin